Annual Current Ratio
10.28
+2.28+28.50%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual current ratio is 10.28, with the most recent change of +2.28 (+28.50%) on December 31, 2023.
- During the last 3 years, ELVN annual current ratio has fallen by -78.07 (-88.36%).
- ELVN annual current ratio is now -88.36% below its all-time high of 88.35, reached on December 1, 2020.
Performance
ELVN Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
17.44
+3.05+21.20%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly current ratio is 17.44, with the most recent change of +3.05 (+21.20%) on September 30, 2024.
- Over the past year, ELVN quarterly current ratio has increased by +3.97 (+29.47%).
- ELVN quarterly current ratio is now -43.67% below its all-time high of 30.96, reached on June 30, 2023.
Performance
ELVN Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
ELVN Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.5% | +29.5% |
| 3 y3 years | -88.4% | -36.0% |
| 5 y5 years | -88.4% | -36.0% |
ELVN Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.6% | +28.5% | -43.7% | +118.0% |
| 5 y | 5-year | -88.4% | +28.5% | -43.7% | +118.0% |
| alltime | all time | -88.4% | +28.5% | -43.7% | +118.0% |
Enliven Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 17.44(+21.2%) |
| Jun 2024 | - | 14.39(+6.8%) |
| Mar 2024 | - | 13.47(+31.0%) |
| Dec 2023 | 10.28 | 10.28(-53.8%) |
| Sep 2023 | - | 22.24(-28.2%) |
| Jun 2023 | - | 30.96(+13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | 27.23(+240.4%) |
| Dec 2022 | 8.00(-58.4%) | 8.00(-24.5%) |
| Sep 2022 | - | 10.59(-45.0%) |
| Dec 2021 | 19.24(-78.2%) | - |
| Dec 2021 | - | 19.24 |
| Dec 2020 | 88.35 | - |
FAQ
- What is Enliven Therapeutics annual current ratio?
- What is the all time high annual current ratio for Enliven Therapeutics?
- What is Enliven Therapeutics annual current ratio year-on-year change?
- What is Enliven Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly current ratio year-on-year change?
What is Enliven Therapeutics annual current ratio?
The current annual current ratio of ELVN is 10.28
What is the all time high annual current ratio for Enliven Therapeutics?
Enliven Therapeutics all-time high annual current ratio is 88.35
What is Enliven Therapeutics annual current ratio year-on-year change?
Over the past year, ELVN annual current ratio has changed by +2.28 (+28.50%)
What is Enliven Therapeutics quarterly current ratio?
The current quarterly current ratio of ELVN is 17.44
What is the all time high quarterly current ratio for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly current ratio is 30.96
What is Enliven Therapeutics quarterly current ratio year-on-year change?
Over the past year, ELVN quarterly current ratio has changed by +3.97 (+29.47%)